Friday, June 6, 2025
  • Login
No Result
View All Result
ForexTV
  • News
    • Top Corporate News
    • Lifestyle
    • Technology
    • Financial Markets News
  • Small Business
    • Digital Marketing Blog
    • Small Business Best Practices
    • Small Business Strategy
      • Sales Strategies
      • Marketing Strategies
  • Business Finance
    • Small Business-Lending Trends
    • Debt Service Coverage Ratio (DSCR)
    • Business Credit
      • Business Credit Blog
      • Business Loans
      • Merchant Cash Advances
      • Business Line of Credit
      • What is Alternative Business Lending?
    • Resources
      • Debt Service Coverage Ratio (DSCR) Calculator
  • Currency Focus
    • Crypto Focus
      • Bitcoin (BTC)
      • Ethereum (ETH)
      • Tether
      • BNB
      • Cardano (Ada)
      • Ripple (XRP)
      • Solana (SOL)
      • Dogecoin (DOGE)
      • Polkadot (DOT)
      • Tron (TRX)
      • Shiba Inu (SHIB)
      • Litecoin (LTC)
    • EURO (EUR)
    • Japanese Yen (JPY)
    • Great British Pound (GBP)
    • Swiss Franc (CHF)
    • New Zealand Dollar (NZD)
    • Canadian Dollar (CAD)
    • Australian Dollar (AUD)
  • Resources
    • Economic Calendar
    • Trader Education
      • Candlestick Pattern Intro
    • Live Forex Rates/Charts
      • Live Rates
      • Live Charts
    • Forex Trader Tools
      • Pivot Point Calculator
      • Currency Converter
      • Global Statistic Resources
    • Trading Terms
      • Forex Glossary
      • Glossary of Retirement Industry Terms
    • CPI Tools
      • CPI Inflation Calculator
      • CPI Average Price Calculator
  • Marketing Services
    • Digital Marketing Services
    • Digital Marketing Consulting
    • Search Engine Optimization (SEO)
    • Online Content Marketing
    • Digital Marketing Blog
    • Inbound Marketing Services
    • Email Marketing
    • Digital Marketing Rates
  • News
    • Top Corporate News
    • Lifestyle
    • Technology
    • Financial Markets News
  • Small Business
    • Digital Marketing Blog
    • Small Business Best Practices
    • Small Business Strategy
      • Sales Strategies
      • Marketing Strategies
  • Business Finance
    • Small Business-Lending Trends
    • Debt Service Coverage Ratio (DSCR)
    • Business Credit
      • Business Credit Blog
      • Business Loans
      • Merchant Cash Advances
      • Business Line of Credit
      • What is Alternative Business Lending?
    • Resources
      • Debt Service Coverage Ratio (DSCR) Calculator
  • Currency Focus
    • Crypto Focus
      • Bitcoin (BTC)
      • Ethereum (ETH)
      • Tether
      • BNB
      • Cardano (Ada)
      • Ripple (XRP)
      • Solana (SOL)
      • Dogecoin (DOGE)
      • Polkadot (DOT)
      • Tron (TRX)
      • Shiba Inu (SHIB)
      • Litecoin (LTC)
    • EURO (EUR)
    • Japanese Yen (JPY)
    • Great British Pound (GBP)
    • Swiss Franc (CHF)
    • New Zealand Dollar (NZD)
    • Canadian Dollar (CAD)
    • Australian Dollar (AUD)
  • Resources
    • Economic Calendar
    • Trader Education
      • Candlestick Pattern Intro
    • Live Forex Rates/Charts
      • Live Rates
      • Live Charts
    • Forex Trader Tools
      • Pivot Point Calculator
      • Currency Converter
      • Global Statistic Resources
    • Trading Terms
      • Forex Glossary
      • Glossary of Retirement Industry Terms
    • CPI Tools
      • CPI Inflation Calculator
      • CPI Average Price Calculator
  • Marketing Services
    • Digital Marketing Services
    • Digital Marketing Consulting
    • Search Engine Optimization (SEO)
    • Online Content Marketing
    • Digital Marketing Blog
    • Inbound Marketing Services
    • Email Marketing
    • Digital Marketing Rates
No Result
View All Result
ForexTV
No Result
View All Result
ADVERTISEMENTS
club Felene

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

by GlobeNewswire
June 5, 2025
in Top News
Reading Time: 4 mins read

Recent independent analyses confirmed that the Company has successfully created a ligand conjugated nanoparticle that can target specific biomarkers on the surface of cancer cells

Lehi, June 05, 2025 (GLOBE NEWSWIRE) — Lehi, Utah – June 5, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform designed to use the body’s immune system to treat cancer, today announced the successful creation of its nanoparticle that can target specific cells that are potentially cancerous.

The Company’s revolutionary approach detects, and universally marks, cancer cells as viruses, such as measles. This tricks the immune system into killing cancer cells as if they were known viruses. To specifically elicit an immune response against cancer cells, CancerVax technology uses a precision 2-step cancer cell detection mechanism in highly functionalized lipid nanoparticles.

Step 1: The nanoparticle latches onto surface proteins highly expressed on cancer cells (“Marker1”). Step 2: The nanoparticle releases a proprietary Smart mRNA payload that is conditionally activated based on cancer genetic signatures (“Marker2”). When the Smart mRNA encounters a cell with the matching cancer-specific signature, it forces the cell to produce viral proteins, which disguises the cancer cell as a virus, such as measles. This makes the cancer cells recognizable to the immune system and induces immune cells to attack and kill the cancer cells. When the Smart mRNA encounters a healthy cell signature, it will not turn on, leaving the healthy cell unharmed. This two-step, on/off cancer signature detection is highly targeted to the cancer cell and is believed to improve the safety and efficacy of its treatments.   

With the help of one of its world-class development partners, the Company successfully attached Marker1 molecules onto the surface of nanoparticles with high efficiency. These Marker1 conjugated nanoparticles can then seek out and deliver Smart mRNAs to cancer cells with the matching surface protein.

Dr. George Katibah, Chief Scientific Officer of CancerVax said, “We anticipate that our targeted nanoparticles will improve delivery of our Smart mRNAs to cancer cells while significantly reducing uptake by healthy cells. This is potentially a game changer for increasing efficacy and reducing toxicity.”

Recent positive lab confirmation demonstrated strong conjugation efficiency, which indicates that our nanoparticles can be manufactured at scale. Additional studies are being conducted to further increase efficiency rates even in preparation for clinical-grade production.

Dr. Katibah commented further, “This is an important milestone for us. In February 2025, we proved that our Smart mRNA containing Marker2 worked. However, we needed a Marker1 nanoparticle to complete our innovative 2-step detection strategy. Now, we have it. These exciting results provide our team with high levels of confidence that we can successfully produce fully functional nanoparticles that can latch on to cancer cells and deliver Smart mRNAs to disguise cancer as a common disease. This is a significant, positive step towards our goal of developing a better way to treat cancer.”

Dr. Adam Grant, Principal Scientist of CancerVax said, “These results are very exciting and confirm that the technology we have designed can be manufactured with limited issues. We evaluated a lot of data to give us the best chance of success, but the rubber meets the road only when we are able to validate our findings in well-designed experiments. I’m excited that what we’re seeing in the data is consistent with the expected results we hypothesized. These successful lab reports confirm that we are on the right path!”

The Company’s next step is to combine Marker2 Smart mRNA payloads into Marker1 nanoparticles and create full therapeutic nanoparticles for further in-vitro optimization, and in-vivo animal testing for efficacy and toxicity.

About CancerVax

CancerVax is a pre-clinical biotech company developing a revolutionary Universal Cancer Treatment platform that will be customizable, as an injection, to treat many types of cancer. Our innovative approach DETECTS, MARKS, and KILLS only cancer cells. By making cancer cells look like well-immunized common diseases such as measles or chickenpox, we intend to use the body’s natural immune system to easily kill the cancer cells. We look forward to the day when treating cancer will be as simple as getting a shot – a better way to fight cancer. To learn more, please visit www.CancerVax.com

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results and financial condition may differ materially from those in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise.

Press Contact:
CancerVax, Inc.
Tel: (805) 356-1810
communications@CancerVax.com

  • Author
  • Recent Posts
GlobeNewswire
GlobeNewswire
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
GlobeNewswire
Latest posts by GlobeNewswire (see all)
  • Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - June 6, 2025
  • Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials - June 6, 2025
  • Bango 2024 Full Year Results and Outlook - June 6, 2025
ADVERTISEMENTS
americas favorite vodka

Related Posts

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

by GlobeNewswire
June 6, 2025
0

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea...

Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

by GlobeNewswire
June 6, 2025
0

PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a...

EUR/USD Outlook: Euro Pauses Rally as ECB Rate Cut Looms

by Forex Crunch
June 6, 2025
0

The EUR/USD outlook shows caution ahead of a likely European Central Bank rate cut. The US private sector added 37,000...

Bango 2024 Full Year Results and Outlook

by GlobeNewswire
June 6, 2025
0

CAMBRIDGE, United Kingdom, June 06, 2025 (GLOBE NEWSWIRE) -- Bango (AIM: BGO), today announces its full year results for the...

Judgment of the Administrative Regional Court of the Republic of Latvia regarding KIA Auto AS and TKM Grupp AS

by GlobeNewswire
June 6, 2025
0

On 5th of June 2025, the Administrative Regional Court of the Republic of Latvia delivered a judgment in a case...

LHV Group’s own share acquisition transactions

by GlobeNewswire
June 6, 2025
0

AS LHV Group announces that on 5 June 2025, it has acquired the company’s own shares on the Nasdaq Tallinn...

Next Post

Tin Rebounds To 1-Week High

Please login to join discussion
ADVERTISEMENTS

Latest Posts

  • Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE June 6, 2025
  • Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials June 6, 2025
  • EUR/USD Outlook: Euro Pauses Rally as ECB Rate Cut Looms June 6, 2025
  • Bango 2024 Full Year Results and Outlook June 6, 2025
  • Judgment of the Administrative Regional Court of the Republic of Latvia regarding KIA Auto AS and TKM Grupp AS June 6, 2025
  • About Us
  • Advertise
  • Careers
  • Contact
Privacy Policy / Terms and Conditions

© 2024 ForexTV.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Cookie Policy
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • News
    • Top Corporate News
    • Lifestyle
    • Technology
    • Financial Markets News
  • Small Business
    • Digital Marketing Blog
    • Small Business Best Practices
    • Small Business Strategy
      • Sales Strategies
      • Marketing Strategies
  • Business Finance
    • Small Business-Lending Trends
    • Debt Service Coverage Ratio (DSCR)
    • Business Credit
      • Business Credit Blog
      • Business Loans
      • Merchant Cash Advances
      • Business Line of Credit
      • What is Alternative Business Lending?
    • Resources
      • Debt Service Coverage Ratio (DSCR) Calculator
  • Currency Focus
    • Crypto Focus
      • Bitcoin (BTC)
      • Ethereum (ETH)
      • Tether
      • BNB
      • Cardano (Ada)
      • Ripple (XRP)
      • Solana (SOL)
      • Dogecoin (DOGE)
      • Polkadot (DOT)
      • Tron (TRX)
      • Shiba Inu (SHIB)
      • Litecoin (LTC)
    • EURO (EUR)
    • Japanese Yen (JPY)
    • Great British Pound (GBP)
    • Swiss Franc (CHF)
    • New Zealand Dollar (NZD)
    • Canadian Dollar (CAD)
    • Australian Dollar (AUD)
  • Resources
    • Economic Calendar
    • Trader Education
      • Candlestick Pattern Intro
    • Live Forex Rates/Charts
      • Live Rates
      • Live Charts
    • Forex Trader Tools
      • Pivot Point Calculator
      • Currency Converter
      • Global Statistic Resources
    • Trading Terms
      • Forex Glossary
      • Glossary of Retirement Industry Terms
    • CPI Tools
      • CPI Inflation Calculator
      • CPI Average Price Calculator
  • Marketing Services
    • Digital Marketing Services
    • Digital Marketing Consulting
    • Search Engine Optimization (SEO)
    • Online Content Marketing
    • Digital Marketing Blog
    • Inbound Marketing Services
    • Email Marketing
    • Digital Marketing Rates

© 2024 ForexTV.com